Auditory hallucinations in Parkinson's disease

被引:121
作者
Inzelberg, R
Kipervasser, S
Korczyn, AD [1 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Dept Neurol, IL-69978 Ramat Aviv, Israel
[2] Tel Aviv Med Ctr & Sch Med, Dept Neurol, Ramat Aviv, Israel
关键词
Parkinson's disease; auditory hallucinations; hallucinations; complications; dopaminergic treatment;
D O I
10.1136/jnnp.64.4.533
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Whereas visual hallucinations are often found among patients with Parkinson's disease, the occurrence of auditory hallucinations has never been systematically documented. The occurrence, past and present, of auditory hallucinations has been studied in 121 consecutive patients with Parkinson's disease attending a movement disorders clinic. The cognitive state was evaluated using the short mental test (SMT). Hallucinations were reported for 45 patients (37%); 35 (29%) had only visual hallucinations and 10 (8%) both visual and auditory hallucinations. No patient reported auditory hallucinations unaccompanied by visual hallucinations. The auditory hallucinations occurred repeatedly, consisting of human voices. They were non-imperative (n=9), non-paranoid (n=9), and often incomprehensible (n=5). They were not obviously influenced by the patients' age, duration of disease, or treatment with levodopa. Cognitive impairment was more common among hallucinating patients (64%, 50%, and 25% among patients with visual hallucinations, auditory hallucinations, and non-hallucinating parkinsonian patients respectively). Depression necessitating antidepressants was present in five of 10 and other psychotic features in six patients with auditory hallucinations. It is concluded that auditory hallucinations occur in Parkinson's disease, particularly in patients who also have visual hallucinations and are cognitively impaired.
引用
收藏
页码:533 / 535
页数:3
相关论文
共 10 条
[1]   PSYCHOSIS AND OTHER PSYCHIATRIC MANIFESTATIONS OF LEVODOPA THERAPY [J].
CELESIA, GG ;
BARR, AN .
ARCHIVES OF NEUROLOGY, 1970, 23 (03) :193-&
[2]  
FERNANDEZ W, 1992, BEHAV NEUROL, V5, P83, DOI 10.3233/BEN-1992-5203
[3]  
FISCHER P, 1990, ADV NEUROL, V53, P391
[4]   TRANSIENT MUSICAL HALLUCINOSIS [J].
INZELBERG, R ;
VISHNIEVSKAYA, S ;
KORCZYN, AD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (07) :833-833
[5]  
MOSKOVITZ C, 1978, AM J PSYCHIAT, V135, P669
[6]   LOW-DOSE CLOZAPINE IN THE TREATMENT OF LEVODOPA-INDUCED MENTAL DISTURBANCES IN PARKINSONS-DISEASE [J].
RABEY, JM ;
TREVES, TA ;
NEUFELD, MY ;
ORLOV, E ;
KORCZYN, AD .
NEUROLOGY, 1995, 45 (03) :432-434
[7]  
SAINTCYR JA, 1993, NEUROLOGY, V43, P47
[8]  
TREVES T, 1990, DEMENTIA, V1, P101
[9]   CLONING OF THE GENE FOR A HUMAN DOPAMINE D4-RECEPTOR WITH HIGH-AFFINITY FOR THE ANTIPSYCHOTIC CLOZAPINE [J].
VANTOL, HHM ;
BUNZOW, JR ;
GUAN, HC ;
SUNAHARA, RK ;
SEEMAN, P ;
NIZNIK, HB ;
CIVELLI, O .
NATURE, 1991, 350 (6319) :610-614
[10]   ONDANSETRON FOR HALLUCINOSIS IN ADVANCED PARKINSONS-DISEASE [J].
ZOLDAN, J ;
FRIEDBERG, G ;
GOLDBERGSTERN, H ;
MELAMED, E .
LANCET, 1993, 341 (8844) :562-563